192 related articles for article (PubMed ID: 34395291)
21. The risk and prognosis of secondary primary malignancy in lung cancer: a population-based study.
Hong J; Wei R; Nie C; Leonteva A; Han X; Du X; Wang J; Zhu L; Tian W; Zhou H
Future Oncol; 2021 Nov; 17(33):4497-4509. PubMed ID: 34402680
[TBL] [Abstract][Full Text] [Related]
22. Risk of second primary malignancy after non-small cell lung cancer: a competing risk nomogram based on the SEER database.
Zhou H; Shen J; Zhang Y; Huang Y; Fang W; Yang Y; Hong S; Liu J; Xian W; Zhang Z; Ma Y; Zhou T; Zhao H; Zhang L
Ann Transl Med; 2019 Sep; 7(18):439. PubMed ID: 31700875
[TBL] [Abstract][Full Text] [Related]
23. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
[TBL] [Abstract][Full Text] [Related]
24. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis.
Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X
Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751
[TBL] [Abstract][Full Text] [Related]
25. Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study.
Yang Y; Yang Y; Yan S
Curr Probl Cancer; 2021 Dec; 45(6):100735. PubMed ID: 33867153
[TBL] [Abstract][Full Text] [Related]
26. Incidence and prognostic significance of second primary cancers in renal cell carcinoma.
Chakraborty S; Tarantolo SR; Batra SK; Hauke RJ
Am J Clin Oncol; 2013 Apr; 36(2):132-42. PubMed ID: 22441339
[TBL] [Abstract][Full Text] [Related]
27. Risk of second primary malignancy in patients with sinonasal tumors: a population-based cohort study.
Ganti A; Plitt MA; Kuan EC; Kuhar HN; Batra PS; Tajudeen BA
Int Forum Allergy Rhinol; 2018 Jun; 8(6):756-762. PubMed ID: 29381260
[TBL] [Abstract][Full Text] [Related]
28. Second Primary Malignancy in Patients with Hypopharyngeal Carcinoma: A SEER-Based Study.
Guo L; Fu Y; Miao C; Wu S; Zhu Y; Liu Y
Int J Gen Med; 2021; 14():8847-8861. PubMed ID: 34858052
[TBL] [Abstract][Full Text] [Related]
29. Impact of second primary malignancy on outcomes of differentiated thyroid carcinoma.
Lang BH; Lo CY; Wong IO; Cowling BJ
Surgery; 2010 Dec; 148(6):1191-6; discussion 1196-7. PubMed ID: 21134551
[TBL] [Abstract][Full Text] [Related]
30. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
Iyer NG; Morris LG; Tuttle RM; Shaha AR; Ganly I
Cancer; 2011 Oct; 117(19):4439-46. PubMed ID: 21432843
[TBL] [Abstract][Full Text] [Related]
31. Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
Goldfarb M; Rosenberg AS; Li Q; Keegan THM
Cancer; 2018 Mar; 124(6):1260-1268. PubMed ID: 29205296
[TBL] [Abstract][Full Text] [Related]
32. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
33. Second primary malignancies in laryngeal carcinoma patients treated with definitive radiotherapy.
Ozdemir Y; Topkan E
Indian J Cancer; 2019; 56(1):29-34. PubMed ID: 30950440
[TBL] [Abstract][Full Text] [Related]
34. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
[TBL] [Abstract][Full Text] [Related]
35. Metachronous second primary malignancy in head and neck cancer patients: is five years of follow-up sufficient?
Adeel M; Siddiqi MI
J Korean Assoc Oral Maxillofac Surg; 2018 Oct; 44(5):220-224. PubMed ID: 30402413
[TBL] [Abstract][Full Text] [Related]
36. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
37. Risk of second primary malignancies in a population-based study of adult patients with essential thrombocythemia.
Shrestha R; Giri S; Pathak R; Bhatt VR
World J Clin Oncol; 2016 Aug; 7(4):324-30. PubMed ID: 27579252
[TBL] [Abstract][Full Text] [Related]
38. Synchronous pulmonary metastases from renal cell carcinoma--a whole nation study on prevalence and potential resectability.
Oddsson SJ; Hardarson S; Petursdottir V; Jonsson E; Sigurdsson MI; Einarsson GV; Pfannschmidt J; Gudbjartsson T
Scand J Surg; 2012; 101(3):160-5. PubMed ID: 22968238
[TBL] [Abstract][Full Text] [Related]
39. Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors.
Abrahão R; Brunson AM; Kahn JM; Li QW; Wun T; Keegan THM
Leuk Lymphoma; 2022 May; 63(5):1091-1101. PubMed ID: 34989283
[TBL] [Abstract][Full Text] [Related]
40. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
